Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objective of this study was to investigate the bioequivalence of Mylan\'s fexofenadine 180 mg tablets to Aventis\' Allegra® 180 mg tablets following a single, oral 180 mg (1 x 180 mg) dose administered under fed conditions.
Epistemonikos ID: 7c8f447908fffd127e08e6342b285f9425e439d4
First added on: May 04, 2024